US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lycia Therapeutics

30.00

+12.0066.67%

Post-market: 26.50-3.5000-11.67%19:59 EDT

Volume:2.29M

Turnover:63.26M

Market Cap:1.56B

PE:- -

High:36.49

Open:28.55

Low:22.19

Close:18.00

52wk High:36.49

52wk Low:22.19

Shares:52.09M

Float Shares:14.70M

Volume Ratio:- -

T/O Rate:15.56%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:-11.83

PE(LYR):- -

Loading ...

Overview Company News Filings

Forget Anthropic: Biotech is Quietly Dominating the IPO Sphere

Forget Anthropic: Biotech is Quietly Dominating the IPO Sphere

Biotech Firm Lycia Therapeutics Makes US Market Debut, Shares Surge Over 32%

Lycia Therapeutics Poised to Soar in NASDAQ Debut After Upsized $317.5 Million IPO

Lycia Therapeutics Prices $318 Million IPO

MT Newswires Live

Lycia Therapeutics: Prices Upsized IPO of 17,640,000 Shares at $18.00 Per Share

THOMSON REUTERS

Lycia Therapeutics Sets IPO Terms at $16-$18 Per Share, Aiming to Raise $250 Million

Lycia Therapeutics Aims to Raise up to $264.6 Million in US IPO

Lycia Therapeutics - IPO Price Expected Between $16 and $18 Per Share - SEC Filing

THOMSON REUTERS

Lycia Therapeutics - to Offer 14,700,000 Shares in Initial Public Offering - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LYCA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LYCA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LYCA\",,,,,undefined,":{"symbol":"LYCA","market":"US","secType":"STK","nameCN":"Lycia Therapeutics","latestPrice":30,"timestamp":1792785600000,"preClose":18,"halted":0,"volume":2287202,"hourTrading":{"tag":"盘后","latestPrice":26.5,"preClose":30,"latestTime":"19:59 EDT","volume":21598,"amount":605931.297,"timestamp":1792799969687,"change":-3.5,"changeRate":-0.116667,"amplitude":0.116667},"delay":0,"changeRate":0.6666666666666666,"floatShares":14700000,"shares":52094559,"eps":0,"marketStatus":"Market Closed","change":12,"latestTime":"10-23 16:00:00 EDT","open":28.55,"high":36.4931,"low":22.19,"amount":63259421.47999,"amplitude":0.794617,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"listingDate":1792728000000,"exchange":"NASDAQ","adjPreClose":18,"postHourTrading":{"tag":"盘后","latestPrice":26.5,"preClose":30,"latestTime":"19:59 EDT","volume":21598,"amount":605931.297,"timestamp":1792799969687,"change":-3.5,"changeRate":-0.116667,"amplitude":0.116667},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LYCA\",,,,,undefined,":{"symbol":"LYCA","floatShares":14700000,"roa":"--","roe":"--","lyrEps":0,"shares":52094559,"dividePrice":0,"high":36.4931,"amplitude":0.794617,"preClose":18,"low":22.19,"week52Low":22.19,"pbRate":"-11.83","psRate":"352.39","week52High":36.4931,"institutionHeld":0,"latestPrice":30,"eps":0,"divideRate":0,"volume":2287202,"delay":0,"ttmEps":0,"open":28.55,"prevYearClose":18,"prevWeekClose":18,"prevMonthClose":18,"prevQuarterClose":18,"fiveDayClose":18,"twentyDayClose":18,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LYCA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LYCA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LYCA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LYCA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2678183534","title":"Forget Anthropic: Biotech is Quietly Dominating the IPO Sphere","url":"https://stock-news.laohu8.com/highlight/detail?id=2678183534","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678183534?lang=en_us&edition=fundamental","pubTime":"2026-10-25 08:27","pubTimestamp":1792888056,"startTime":"0","endTime":"0","summary":"The initial public offering market has been in a lull as investors continue to wait for Claude developer Anthropic to officially file a S-1 form, with just a handful of companies making their public...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IPO","KCE","BK4127","XBI","BK4581","CTY","IPOS","LYCA","FRHC","BK4585","REDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678183325","title":"Forget Anthropic: Biotech is Quietly Dominating the IPO Sphere","url":"https://stock-news.laohu8.com/highlight/detail?id=2678183325","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678183325?lang=en_us&edition=fundamental","pubTime":"2026-10-25 02:56","pubTimestamp":1792868160,"startTime":"0","endTime":"0","summary":"The initial public offering market has been in a lull as investors continue to wait for Claude developer Anthropic to officially file a S-1 form, with a handful of companies making their public debuts","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","IPO","REDS","BK4581","KCE","LYCA","CTY","FRHC","BK4588","XBI","BK4585","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161901255","title":"Biotech Firm Lycia Therapeutics Makes US Market Debut, Shares Surge Over 32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161901255","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161901255?lang=en_us&edition=fundamental","pubTime":"2026-10-24 00:36","pubTimestamp":1792773372,"startTime":"0","endTime":"0","summary":"On Friday, biotech company Lycia Therapeutics (LYCA.US), which focuses on treatments for allergies and autoimmune diseases, made its debut on the US stock market. Its shares surged more than 32%...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LNGR","LYCA","BK4539","159837","BK4139","BK4007","BK4585","HBImain","GDOC","SYNB","XBI","IEIH","AGNG","BK4581","BK4588","IBBJ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677797555","title":"Lycia Therapeutics Poised to Soar in NASDAQ Debut After Upsized $317.5 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2677797555","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677797555?lang=en_us&edition=fundamental","pubTime":"2026-10-23 23:02","pubTimestamp":1792767745,"startTime":"0","endTime":"0","summary":"BUZZ-Lycia Therapeutics poised to soar in Nasdaq debut after upsized $317.5 million IPO** Lycia TherapeuticsLYCA.Oset to open higher in Nasdaq debut after upsized $317.5 million US IPO** Drug develope","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nL6N4690RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYCA","EVR","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677949383","title":"Lycia Therapeutics Prices $318 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2677949383","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677949383?lang=en_us&edition=fundamental","pubTime":"2026-10-23 15:43","pubTimestamp":1792741391,"startTime":"0","endTime":"0","summary":"Lycia Therapeutics (LYCA) has priced its initial public offering of 17.6 million common shares at $18 each, for expected gross proceeds of about $317.5 million, the company said late Thursday.Underwri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4127","KCE","FRHC","LYCA","REDS","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677990424","title":"Lycia Therapeutics: Prices Upsized IPO of 17,640,000 Shares at $18.00 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2677990424","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677990424?lang=en_us&edition=fundamental","pubTime":"2026-10-23 07:54","pubTimestamp":1792713249,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nFWN4682Q8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LYCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101331322","title":"Lycia Therapeutics Sets IPO Terms at $16-$18 Per Share, Aiming to Raise $250 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1101331322","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101331322?lang=en_us&edition=fundamental","pubTime":"2026-10-21 15:00","pubTimestamp":1792566020,"startTime":"0","endTime":"0","summary":"Biotechnology company Lycia Therapeutics Inc (NASDAQ: LYCA) announced the terms of its initial public offering on Tuesday.The South San Francisco, California-based company plans to raise $250 million...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","UUP","LYCA","LENZ","UDN","BK4007","IPOS","BK4139","HELX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676664976","title":"Lycia Therapeutics Aims to Raise up to $264.6 Million in US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2676664976","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676664976?lang=en_us&edition=fundamental","pubTime":"2026-10-20 18:12","pubTimestamp":1792491169,"startTime":"0","endTime":"0","summary":"Lycia Therapeutics aims to raise up to $264.6 million in US IPOOct 20 (Reuters)-Drug developer Lycia Therapeutics said on Tuesday it was aiming to raise as much as $264.6 million in its US initial public offering.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nL4N4660LJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676664609","title":"Lycia Therapeutics - IPO Price Expected Between $16 and $18 Per Share - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2676664609","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676664609?lang=en_us&edition=fundamental","pubTime":"2026-10-20 18:10","pubTimestamp":1792491039,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nFWN46616N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LYCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676603664","title":"Lycia Therapeutics - to Offer 14,700,000 Shares in Initial Public Offering - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2676603664","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676603664?lang=en_us&edition=fundamental","pubTime":"2026-10-20 18:10","pubTimestamp":1792491039,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nFWN46616N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LYCA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}